Participations aux congrès
Chaque année, le CNR Herpèsvirus participe à de nombreux congrès:
Cliquez sur l’icone pour accéder au site:
ECCI: Eurpean Congenital Cytomegalovirus Initiative 
Workshop CMV 
ESCV European Society of Clinical Virology 
SFM: Société Française de Microbiologie 
RICAI: Réunion interdisciplinaire de Chimiothérapie AntiInfectieuse 
ECMID: European Congress of Clinical Microbiology and Infectiuous Deseases 
Dernières présentations du CNR:
2025
-
BiomedJ 2025 – CMV et grossesse : nouvelles recommandations du HCSP : arguments pour le dépistage
- JNI juin 2025 L’infection à CMV chez le transplanté : quelles options en cas de résistance ou situation réfractaire ?
-
Que retenir du CMV en janvier 2025 ? Infections congénitales, Greffes de cellules souches, Vaccin
- 27th ESCV september 2025 : Comprehensive Herpesviruses Antiviral Resistance Mutation Database (CHARMD) and HSA tool for easy cytomegalovirus genotyping interpretation
2024:
- Insights intoCMV RNA A French perspective on lung solid organ transplantation Preliminary results in cell culture and patients
- Congrès SFT Marseille CMV et nouvelles thérapeutiques S Alain
-
Gestion du risque CMV en post greffe SFM
- Congenital CMV infection in France: maternal and neonatal treatements, data from the French “congenital CMV declaration platform” of the National Reference Center for Herpesviruses 2024
- Comparison of the ELITech Be Genius® and the SaMag extraction/Rgene® PCR for cCMV diagnosis on DBS
2023:
2022:
- CMV resistance to antivirals is still an unmet need Results from the French National surveillance 2006-2020
- First description of Letermovir resistance mutation in UL51 gene from a HSCT-patient and study of its impact on the terminase complex structure
- Poster CMV resistance to antivirals is still an unmet need Results from the French National surveillance 2006-2020
- Potential of anti-CMV Immunoglobulins Cytotect®in vitro and ex vivoin first-trimester placenta model
- Quantiferon-CMV Assay And TTV Viremia in Prediction of Cytomegalovirus Reactivation in R+ Kidney Transplant Recipients
- Surveillance of CMV resistance to antivirals in France 14 years survey and focus on new antivirals
- Viremie CMV Viremie CMV conduite a tenir SFGM-TC Nov 2022
- Congenital CMV infection in France_the burden of severe cases in the absence of systematic screening
- OUEST TRANSPLANT 2022 – Charge virale TTV et greffe, quelles applications clíniques ?
2021:
- Evaluation prospective du risque d’infection àCMV du sujet transplanté rénal R+ par le test QuantiFERON®-CMV et la PCR TTV
- Unmet needs inmaternal diagnosis and treatment for congenital cmv in france
- When CMV is playing unfair, how to breakthrough cmv resistance?
2020: